glp 1 receptor agonist agent A Closer Look at the Dermatological Profile of GLP-1 Agonists GLP-1 Receptor Agonists as Treatments
Description
As online weight-loss clinics boom, reports of GLP-1 overdoses, dosing mistakes, and hospitalizations are climbing.
Learn more about its role in diabetes management.
David Joffe, BSPharm, CDE Tina Burge, PharmD Candidate Florida A&M University Kiet Ngo, Pharm D Candidate Mercer University Abnormalities in incretin
Once Monthly GLP-1 Maridebart cafraglutide is an investigational once-monthly injectable drug developed by Amgen that shows significant promise for treating obesity and Type 2 diabetes
People generally report mild to no pain with the injection
